Cargando…

The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up

PURPOSE: No single pharmacy in an urban zip code is consistently the least expensive across medications. If medication prices change differently across pharmacies, patients and clinicians will face challenges accessing affordable medications when refilling medications. This is especially pertinent t...

Descripción completa

Detalles Bibliográficos
Autores principales: Etteldorf, Andrew, Sedhom, Ramy, Rotolo, Shannon M., Vogel, Rachel I., Booth, Christopher M., Blaes, Anne H., Virnig, Beth A., Dusetzina, Stacie B., Gupta, Arjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745713/
https://www.ncbi.nlm.nih.gov/pubmed/36512134
http://dx.doi.org/10.1007/s00520-022-07472-x
_version_ 1784849208713412608
author Etteldorf, Andrew
Sedhom, Ramy
Rotolo, Shannon M.
Vogel, Rachel I.
Booth, Christopher M.
Blaes, Anne H.
Virnig, Beth A.
Dusetzina, Stacie B.
Gupta, Arjun
author_facet Etteldorf, Andrew
Sedhom, Ramy
Rotolo, Shannon M.
Vogel, Rachel I.
Booth, Christopher M.
Blaes, Anne H.
Virnig, Beth A.
Dusetzina, Stacie B.
Gupta, Arjun
author_sort Etteldorf, Andrew
collection PubMed
description PURPOSE: No single pharmacy in an urban zip code is consistently the least expensive across medications. If medication prices change differently across pharmacies, patients and clinicians will face challenges accessing affordable medications when refilling medications. This is especially pertinent to people with cancer with multiple fills of supportive care medications over time. We evaluated if the lowest-priced pharmacy for a formulation remains the lowest-priced over time. METHODS: We compiled generic medications used to manage nausea/vomiting (14 formulations) and anorexia/cachexia (12 formulations). We extracted discounted prices in October 2021 and again in March 2022 for a typical fill at 8 pharmacies in Minneapolis, Minnesota, USA (zip code 55,414) using GoodRx.com. We examined how prices changed across formulations and pharmacies over time. RESULTS: Data were available for all 208 possible pharmacy-formulation combinations (8 pharmacies × 26 formulations). For 172 (83%) of the 208 pharmacy-formulation combinations, the March 2022 price was within 20% of the October 2021 price. Across pharmacy-formulation combinations, the price change over time ranged from − 76 to + 292%. For 12 (46%) of the 26 formulations, at least one pharmacy with the lowest price in October 2021 no longer was the least costly in March 2022. For one formulation (dronabinol tablets), the least expensive pharmacy became the most expensive, with an absolute and relative price increase of a fill of $22 and 85%. CONCLUSION: For almost half of formulations studied, at least one pharmacy with the lowest price was no longer the least costly a few months later. The lowest price for a formulation (across pharmacies) could also change considerably. Thus, even if a patient accesses the least expensive pharmacy for a medication, they may need to re-check prices across all pharmacies with each subsequent fill to access the lowest prices. In addition to safety concerns, directing medications to and accessing medications at multiple pharmacies can add time and logistic toxicity to patients with cancer, their care partners, prescribers, and pharmacy teams.
format Online
Article
Text
id pubmed-9745713
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-97457132022-12-13 The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up Etteldorf, Andrew Sedhom, Ramy Rotolo, Shannon M. Vogel, Rachel I. Booth, Christopher M. Blaes, Anne H. Virnig, Beth A. Dusetzina, Stacie B. Gupta, Arjun Support Care Cancer Research PURPOSE: No single pharmacy in an urban zip code is consistently the least expensive across medications. If medication prices change differently across pharmacies, patients and clinicians will face challenges accessing affordable medications when refilling medications. This is especially pertinent to people with cancer with multiple fills of supportive care medications over time. We evaluated if the lowest-priced pharmacy for a formulation remains the lowest-priced over time. METHODS: We compiled generic medications used to manage nausea/vomiting (14 formulations) and anorexia/cachexia (12 formulations). We extracted discounted prices in October 2021 and again in March 2022 for a typical fill at 8 pharmacies in Minneapolis, Minnesota, USA (zip code 55,414) using GoodRx.com. We examined how prices changed across formulations and pharmacies over time. RESULTS: Data were available for all 208 possible pharmacy-formulation combinations (8 pharmacies × 26 formulations). For 172 (83%) of the 208 pharmacy-formulation combinations, the March 2022 price was within 20% of the October 2021 price. Across pharmacy-formulation combinations, the price change over time ranged from − 76 to + 292%. For 12 (46%) of the 26 formulations, at least one pharmacy with the lowest price in October 2021 no longer was the least costly in March 2022. For one formulation (dronabinol tablets), the least expensive pharmacy became the most expensive, with an absolute and relative price increase of a fill of $22 and 85%. CONCLUSION: For almost half of formulations studied, at least one pharmacy with the lowest price was no longer the least costly a few months later. The lowest price for a formulation (across pharmacies) could also change considerably. Thus, even if a patient accesses the least expensive pharmacy for a medication, they may need to re-check prices across all pharmacies with each subsequent fill to access the lowest prices. In addition to safety concerns, directing medications to and accessing medications at multiple pharmacies can add time and logistic toxicity to patients with cancer, their care partners, prescribers, and pharmacy teams. Springer Berlin Heidelberg 2022-12-13 2023 /pmc/articles/PMC9745713/ /pubmed/36512134 http://dx.doi.org/10.1007/s00520-022-07472-x Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research
Etteldorf, Andrew
Sedhom, Ramy
Rotolo, Shannon M.
Vogel, Rachel I.
Booth, Christopher M.
Blaes, Anne H.
Virnig, Beth A.
Dusetzina, Stacie B.
Gupta, Arjun
The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up
title The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up
title_full The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up
title_fullStr The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up
title_full_unstemmed The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up
title_short The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up
title_sort least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745713/
https://www.ncbi.nlm.nih.gov/pubmed/36512134
http://dx.doi.org/10.1007/s00520-022-07472-x
work_keys_str_mv AT etteldorfandrew theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT sedhomramy theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT rotoloshannonm theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT vogelracheli theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT boothchristopherm theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT blaesanneh theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT virnigbetha theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT dusetzinastacieb theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT guptaarjun theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT etteldorfandrew leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT sedhomramy leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT rotoloshannonm leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT vogelracheli leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT boothchristopherm leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT blaesanneh leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT virnigbetha leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT dusetzinastacieb leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup
AT guptaarjun leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup